KANSAS U COBRE: PREIMPLANTATION RELEASED PROTEINS EMBRYO QUALITY PREDICTORS

堪萨斯大学 COBRE：植入前释放的蛋白质胚胎质量预测因子

• 批准号: 7610806
• 负责人: LANE K. CHRISTENSON
• 金额: $ 23.93万
• 依托单位: UNIVERSITY OF KANSAS MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-09-27 至 2008-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7610806
• 关键词: Assisted Reproductive Technology; Biochemical Process; Biological Assay; Child; Child health care; Competence; Computer Retrieval of Information on Scientific Projects Database; Conditioned Culture Media; Congenital Abnormality; Development; Embryo; Embryo Transfer; Evaluation; Event; Exhibits; Funding; Goals; Grant; Human; In Vitro; Institution; Invasive; Kansas; Link; Low Birth Weight Infant; Methods; Molecular; Morbidity - disease rate; Multiple Birth Offspring; Mus; Numbers; Pattern; Pregnancy; Pregnancy Outcome; Premature Birth; Proteins; Range; Rate; Research; Research Personnel; Resources; Risk; Selection Criteria; Source; System; Technology; Therapeutic; Time; United States National Institutes of Health; base; embryonic protein; implantation; improved; in vivo; reproductive; stem; success; tandem mass spectrometry

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Presently, -1% of children born each year in the USA are conceived via assisted reproductive technologies (ART) and world-wide >1 million children have been conceived and delivered over the last 2 decades. Children conceived through ART are more likely to exhibit low birth weights and to be delivered prematurely. Much of the morbidity that stems from ART is due to the high rate of multiple gestations associated with this treatment. To date, embryo quality assessments are based on a subjective morphological evaluation of the embryo following in vitro culture. Objective criteria for selection of high quality embryos should increase ART success and make single embryo transfer a more viable therapeutic option. Thus, there is a compelling case for the development of analytical and non-invasive assays that predict embryo quality. The long-range goal of this research is to link molecular, cellular and biochemical processes occurring in the early embryo prior to implantation to developmental events that ultimately result in a successful pregnancy. The hypothesis of the proposed research is that the early embryo secretes/releases proteins that reflect the developmental competence of that embryo. This proposal will identify en masse for the first time early embryonic secreted/ released protein markers in conditioned medium to begin to establish a signature/pattern of proteins indicative of embryo quality. Aim 1 will identify secreted/released protein(s) from murine embryos exhibiting qualitative differences using tandem mass spectrometry. Aim 2 will validate whether these proteins can be used to predict in vivo embryo quality and whether the murine system is translatable to the human system. Furthermore, we will establish a human embryonic conditioned medium bank from single embryo transfers that will allow us to establish a relationship between protein profiles and pregnancy outcome. Children conceived using assisted reproductive technologies (ART) are at a greater risk for birth defects and premature delivery and low birth weights. Identification of factors that can predict embryo quality will provide objective criteria for embryo selection and will reduce the number multiple birth pregnancies (by facilitating single embryo transfer). The long-term benefits are the development of safe methods for determining embryo quality, improvement of ART methods and ultimately improving the health of the children conceived through ART.

这个子项目是众多研究子项目之一